Pre-treatment with SU5416 (VEGFR-1 antagonist), BD1047 (sigma receptor antagonist) or NADPH oxidase inhibitor significantly attenuated the Tat and cocaine mediated endothelial dysfunction (150). The gene discussed is TAT; the disease is endothelial dysfunction.